RemedyRepack Inc. is recalling 75 vials of Ketorolac Tromethamine (30 mg/1mL), a prescription nonsteroidal anti-inflammatory drug (NSAID) used for pain management. The medication was relabeled at a facility and is being recalled because the original manufacturer discovered small black particles during a routine visual inspection of retain samples. These particles were found in 1 ml vials distributed in Oklahoma and Louisiana between June 2018 and November 2018.
The presence of particulate matter in an injectable medication can cause serious health issues, including inflammation, allergic reactions, and the blockage of blood vessels, which could lead to a stroke, heart attack, or damage to other organs.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.